So, I declined to use it, figuring the risk was too great. The drug in question was also very new to the market. This leads ...

During a live event, Mark J. Fesler, MD, and participants discuss next steps for a 68-year-old patient with intermediate-risk ...

Researchers sourced data from the EASE-2 and -3 clinical trials to assess the effect of SGLT2i use on cardiovascular disease risk among patients with type 1 diabetes.

Adults with MI and ADHD exhibit similar cardiometabolic profiles but are 53% more likely to smoke and show double the all-cause mortality rate than those without ADHD, a study finds.

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with ...

Incorporating the 40-GEP test with BWH staging and NCCN risk group significantly improved risk stratification.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Although recommended, many patients with metastatic clear cell RCC still don’t receive immune checkpoint inhibitor-based combinations as first-line treatment.

Asking your specialist is another good idea. Your cardiologist knows you, and although they might not know every new drug, ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...